{"id":732,"date":"2024-05-21T09:31:19","date_gmt":"2024-05-21T09:31:19","guid":{"rendered":"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/?page_id=732"},"modified":"2024-06-26T19:41:10","modified_gmt":"2024-06-26T19:41:10","slug":"platform","status":"publish","type":"page","link":"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/platform\/","title":{"rendered":"Platform"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Banner Section&#8221; module_class=&#8221;lightBlueShape innerBanner&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_enable_image=&#8221;off&#8221; background_video_mp4=&#8221;https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-content\/uploads\/2024\/06\/iStock-537852616-edit.mp4&#8243; height=&#8221;500px&#8221; overflow-x=&#8221;hidden&#8221; overflow-y=&#8221;hidden&#8221; custom_padding=&#8221;180px||180px||true|false&#8221; bottom_divider_height=&#8221;500px&#8221; hover_enabled=&#8221;0&#8243; da_popup_slug=&#8221;platform&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; title_text=&#8221;iStock-537852616-edit&#8221; sticky_enabled=&#8221;0&#8243; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; overflow-x=&#8221;hidden&#8221; overflow-y=&#8221;hidden&#8221; custom_margin=&#8221;|60px||60px|false|true&#8221; custom_margin_tablet=&#8221;|20px||20px|false|true&#8221; custom_margin_phone=&#8221;|20px||20px|false|true&#8221; custom_margin_last_edited=&#8221;on|tablet&#8221; custom_padding_tablet=&#8221;0px||0px||false|false&#8221; custom_padding_phone=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Vertical Line&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; positioning=&#8221;absolute&#8221; width=&#8221;100%&#8221; height=&#8221;100%&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;top&#8221; border_width_left=&#8221;6px&#8221; border_color_left=&#8221;#FFFFFF&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_text][et_pb_cta title=&#8221;Platform&#8221; admin_label=&#8221;Call To Action&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Nunito Sans|700||on|||||&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_font_size=&#8221;20px&#8221; header_letter_spacing=&#8221;1px&#8221; header_line_height=&#8221;20px&#8221; body_font=&#8221;Nunito Sans|300||on|||||&#8221; body_text_color=&#8221;#FFFFFF&#8221; body_font_size=&#8221;40px&#8221; body_letter_spacing=&#8221;0.5px&#8221; body_line_height=&#8221;44px&#8221; use_background_color=&#8221;off&#8221; text_orientation=&#8221;left&#8221; max_width=&#8221;500px&#8221; custom_padding=&#8221;10px||10px|25px|true|false&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;left&#8221; animation_delay=&#8221;900ms&#8221; body_font_size_tablet=&#8221;36px&#8221; body_font_size_phone=&#8221;30px&#8221; body_font_size_last_edited=&#8221;on|tablet&#8221; body_letter_spacing_tablet=&#8221;0.5px&#8221; body_letter_spacing_phone=&#8221;0.5px&#8221; body_letter_spacing_last_edited=&#8221;on|desktop&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Turning disruptive<br \/>targets into<br \/>transformational<br \/>therapies<\/p>\n<p>[\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;TK Section&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;49px||49px||true|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row column_structure=&#8221;2_5,3_5&#8243; use_custom_gutter=&#8221;on&#8221; gutter_width=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; width_tablet=&#8221;100%&#8221; width_phone=&#8221;100%&#8221; width_last_edited=&#8221;on|tablet&#8221; overflow-x=&#8221;hidden&#8221; overflow-y=&#8221;hidden&#8221; custom_padding_tablet=&#8221;0px|20px|0px|20px|false|false&#8221; custom_padding_phone=&#8221;|20px|||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_5&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_heading title=&#8221;our unbiased approach&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; title_level=&#8221;h2&#8243; title_font=&#8221;Nunito Sans|900||on|||||&#8221; title_text_color=&#8221;#3E92AC&#8221; title_font_size=&#8221;24px&#8221; custom_margin=&#8221;25px||12px||false|false&#8221; custom_margin_tablet=&#8221;0px||||false|false&#8221; custom_margin_phone=&#8221;0px||||false|false&#8221; custom_margin_last_edited=&#8221;on|tablet&#8221; animation_style=&#8221;fade&#8221; animation_delay=&#8221;1100ms&#8221; title_font_size_tablet=&#8221;20px&#8221; title_font_size_phone=&#8221;20px&#8221; title_font_size_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_heading][et_pb_text _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;Nunito Sans||||||||&#8221; text_text_color=&#8221;rgba(0,0,0,0.6)&#8221; text_font_size=&#8221;20px&#8221; text_line_height=&#8221;27px&#8221; animation_style=&#8221;fade&#8221; animation_delay=&#8221;1100ms&#8221; text_font_size_tablet=&#8221;18px&#8221; text_font_size_phone=&#8221;18px&#8221; text_font_size_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><strong>Our CRISPRomics<sup>\u00ae<\/sup> platform has enabled us to do what no other company had done before&mdash;<\/strong>perform genome-scale knockouts across a wide range of immune and cancer cells in disease-relevant models to discover the right targets and develop the right therapies for patients with solid tumors.<\/p>\n<p><strong><span style=\"color: #f47920;\">And this was just the beginning.<\/span><\/strong><\/p>\n<p>Applying an unbiased approach, we were able to leverage our disease models to query &gt;20,000 genes&mdash;<strong>the entirety of the genome<\/strong>&mdash;across more than 600 cancer lines and immune cell types, including <strong>T cells, NK cells, and T regulatory cells,<\/strong> to determine which therapeutic targets could be of most benefit to patients. We then discovered and are advancing the most promising therapeutic candidates to fight disease.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;3_5&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; custom_padding_tablet=&#8221;30px||||false|false&#8221; custom_padding_phone=&#8221;30px||||false|false&#8221; custom_padding_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-content\/uploads\/2024\/06\/knowledgebase-top.png&#8221; alt=&#8221;knowledgebase-top&#8221; title_text=&#8221;knowledgebase-top&#8221; show_bottom_space=&#8221;off&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; transform_translate_linked=&#8221;off&#8221; overflow-y=&#8221;hidden&#8221; animation_style=&#8221;slide&#8221; animation_direction=&#8221;top&#8221; animation_duration=&#8221;1500ms&#8221; animation_delay=&#8221;2000ms&#8221; scroll_vertical_motion=&#8221;0|50|50|100|-4|0|0&#8243; scroll_fade=&#8221;0|45|45|100|0|0%|100&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_image src=&#8221;https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-content\/uploads\/2024\/06\/KSQ_web_graphic_platform_portion_new.png&#8221; alt=&#8221;knowledgebase-bottom&#8221; title_text=&#8221;KSQ_web_graphic_platform_portion_new&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; transform_translate_linked=&#8221;off&#8221; animation_style=&#8221;fade&#8221; animation_direction=&#8221;top&#8221; animation_delay=&#8221;500ms&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Section&#8221; module_id=&#8221;scrollToNext&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; da_popup_slug=&#8221;scrollToNext&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; width_tablet=&#8221;100%&#8221; width_phone=&#8221;100%&#8221; width_last_edited=&#8221;on|tablet&#8221; custom_padding_tablet=&#8221;10px|20px||20px|false|false&#8221; custom_padding_phone=&#8221;|20px||20px|false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_heading title=&#8221;Our screens have elucidated high-value targets, including:&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; title_level=&#8221;h3&#8243; title_font=&#8221;|700|||||||&#8221; title_text_color=&#8221;rgba(0,0,0,0.6)&#8221; title_font_size=&#8221;24px&#8221; title_line_height=&#8221;28px&#8221; custom_margin=&#8221;0px||20px||false|false&#8221; custom_padding=&#8221;30px||20px||false|false&#8221; title_font_size_tablet=&#8221;20px&#8221; title_font_size_phone=&#8221;20px&#8221; title_font_size_last_edited=&#8221;on|tablet&#8221; border_width_top=&#8221;6px&#8221; border_color_top=&#8221;#F47920&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_heading][et_pb_code _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; custom_margin_tablet=&#8221;||||false|false&#8221; custom_margin_phone=&#8221;||||false|false&#8221; custom_margin_last_edited=&#8221;on|tablet&#8221; custom_padding_tablet=&#8221;&#8221; custom_padding_phone=&#8221;||40px||false|false&#8221; custom_padding_last_edited=&#8221;on|phone&#8221; border_width_bottom=&#8221;6px&#8221; border_color_bottom=&#8221;#F47920&#8243; global_colors_info=&#8221;{}&#8221;]\n<div class=\"tabbed-content\">\n    <nav class=\"tabs\">\n        <ul>\n    \n          <li><a  href=\"javascript:void();\" data-index=\"2963\" class=\"active cls_2963\">SOCS1<\/a><\/li>\n    \n          <li><a  href=\"javascript:void();\" data-index=\"2964\" class=\" cls_2964\">Regnase-1<\/a><\/li>\n    \n          <li><a  href=\"javascript:void();\" data-index=\"2965\" class=\" cls_2965\">USP1<\/a><\/li>\n<\/ul>\n<\/nav>\n      <section id=\"section_2963\" class=\"item active\" data-title=\"SOCS1\">\n        <div class=\"item-content\">\n          <div class=\"rowContainer\">\n            <div class=\"column\">\n              <ul>\r\n \t<li><strong>SOCS1 stands for: Suppressor Of Cytokine Signaling 1.<\/strong> <strong>SOCS1<\/strong> is a negative regulator of T cell signaling by cytokines, the small proteins critical in controlling the growth and activity of immune cells responding to pathogens and cancer.<\/li>\r\n \t<li><strong>We identified SOCS1 as a top target<\/strong> using our Immune CRISPRomics platform. Editing <strong>SOCS1<\/strong> in TIL using CRISPR\/Cas9 has demonstrated remarkable tumor-killing activity in in vivo mouse cancer models, including those refractory to inhibition by PD-1.<\/li>\r\n \t<li><strong>Our lead eTIL program, <span style=\"color: #f47920;\"><a href=\"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/pipeline\/#KSQ-001EX\" rel=\"noopener\">KSQ-001EX<\/a>,<\/span><\/strong> is a CRISPR\/Cas9 gene-edited eTIL with the <strong>SOCS1<\/strong> gene inactivated. We are currently evaluating <strong>KSQ-001EX<\/strong> in the clinic in patients with a variety of treatment-refractory solid tumors.<\/li>\r\n<\/ul>            <\/div>\n            <div class=\"column\">\n              <p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1280 size-full\" src=\"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-content\/uploads\/2024\/06\/KSQ_web_graphic_socs1.png\" alt=\"KSQ_web_graphic_socs1\" width=\"621\" height=\"797\" srcset=\"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-content\/uploads\/2024\/06\/KSQ_web_graphic_socs1.png 621w, https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-content\/uploads\/2024\/06\/KSQ_web_graphic_socs1-480x616.png 480w\" sizes=\"auto, (min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 621px, 100vw\" \/><\/p>\n            <\/div>\n          <\/div>\n        <\/div>\n      <\/section>\n      <section id=\"section_2964\" class=\"item \" data-title=\"Regnase-1\">\n        <div class=\"item-content\">\n          <div class=\"rowContainer\">\n            <div class=\"column\">\n              <ul>\r\n \t<li><strong>Regnase-1 is an endonuclease that regulates immune responses by<\/strong> degrading the messenger RNA (mRNA) of pro-inflammatory proteins.<\/li>\r\n \t<li>Using our in vivo <strong>CRISPR<\/strong><sup><strong>2<\/strong>TM<\/sup> dual gene-editing screening approach, <strong>we identified Regnase-1 and SOCS1 as the genome\u2019s top dual-edit combination in T cells,<\/strong> synergizing to drive best-in-biology activity in mouse cancer models that are refractory to all other therapies.<\/li>\r\n \t<li><b>We have translated these findings<\/b>\u00a0to our second eTIL program,\u00a0<a href=\"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/pipeline\/#KSQ-004EX\"><b>KSQ-004EX<\/b><\/a>,\u00a0a\u00a0<b>Regnase-1 + SOCS1<\/b>\u00a0dual-edited eTIL.<\/li>\r\n<\/ul>            <\/div>\n            <div class=\"column\">\n              <p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-1279 size-full\" src=\"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-content\/uploads\/2024\/06\/KSQ_web_graphic_regnase_new.png\" alt=\"KSQ_web_graphic_regnase_new\" width=\"747\" height=\"742\" srcset=\"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-content\/uploads\/2024\/06\/KSQ_web_graphic_regnase_new.png 747w, https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-content\/uploads\/2024\/06\/KSQ_web_graphic_regnase_new-480x477.png 480w\" sizes=\"auto, (min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 747px, 100vw\" \/><\/p>\n            <\/div>\n          <\/div>\n        <\/div>\n      <\/section>\n      <section id=\"section_2965\" class=\"item \" data-title=\"USP1\">\n        <div class=\"item-content\">\n          <div class=\"rowContainer\">\n            <div class=\"column\">\n              <ul>\r\n \t<li><strong>USP1 was identified using our Targeted Oncology CRISPRomics platform<\/strong>\u00a0due to its profile as selectively essential in certain biomarker-enabled cancer cell models and its role in DNA damage repair processes (DDR).<\/li>\r\n \t<li><strong>USP1 is a member of the ubiquitin-specific processing (UBP) family <\/strong>of proteases with a role in DDR distinct from other mechanisms currently being evaluated in the clinic, including PARP inhibitors, which have shown significant clinical utility and opened up a new field of targeted oncology exploiting an approach known as \u201csynthetic lethality.\u201d<\/li>\r\n<\/ul>            <\/div>\n            <div class=\"column\">\n              <ul>\n<li><a href=\"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/pipeline\/#KSQ-4279\"><b>KSQ-4279<\/b><\/a><b>\u00a0is a first-in-class, potent, and selective small molecule inhibitor\u00a0of USP1\u00a0<\/b>that has demonstrated strong activity in BRCA mutant preclinical cancer models, including strong combination activity with PARP inhibitors.<\/li>\n<li>In July 2023, we entered into a worldwide license and collaboration agreement with Roche\u00a0for the development and commercialization of\u00a0<a href=\"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/pipeline\/#KSQ-4279\"><b>KSQ-4279<\/b><\/a>; under the collaboration, Roche has assumed all clinical development responsibilities for\u00a0<strong>KSQ-4279 (now RO7623066)<\/strong>.<\/li>\n<\/ul>\n            <\/div>\n          <\/div>\n        <\/div>\n      <\/section>\n      \n\n   \n <\/div>\n \n\n   <script src=\"https:\/\/cdnjs.cloudflare.com\/ajax\/libs\/jquery\/1.11.1\/jquery.min.js\" type=\"text\/javascript\" crossorigin=\"anonymous\"><\/script>\n   <script type=\"text\/javascript\">\njQuery( document ).ready(function() {\n    tabControl();\n\n      var resizeTimer;\n      $(window).on('resize', function(e) {\n        clearTimeout(resizeTimer);\n        resizeTimer = setTimeout(function() {\n          tabControl();\n        }, 250);\n      });\n\n      function tabControl() {\n        var tabs = $('.tabbed-content').find('.tabs');\n        if(tabs.is(':visible')) {\n          tabs.find('a').on('click', function(event) {\n            event.preventDefault();\n            \/\/var target = $(this).attr('href'),\n            var target = $(this).data(\"index\"); \n                tabs = $(this).parents('.tabs'),\n                buttons = tabs.find('a'),\n                item = tabs.parents('.tabbed-content').find('.item');\n            buttons.removeClass('active');\n            item.removeClass('active');\n            $(this).addClass('active');\n            \/\/$(target).addClass('active');\n            $('#section_'+target).addClass('active');\n          });\n        } else {\n          $('.item').on('click', function() {\n            var container = $(this).parents('.tabbed-content'),\n                currId = $(this).attr('id'),\n                items = container.find('.item');\n            container.find('.tabs a').removeClass('active');\n            items.removeClass('active');\n            $(this).addClass('active');\n            \/\/container.find('.tabs a[href$=\"#'+ currId +'\"]').addClass('active');\n            \/\/container.find('.tabs a[href$=\"#'+ currId +'\"]').addClass('active');\n            $('.cls_'+ currId).addClass('active');\n          });\n        } \n      }\n});\n   <\/script>\n[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;OUR PROPRIETARY&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||||false|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row custom_padding_last_edited=&#8221;on|desktop&#8221; module_class=&#8221;alignItemsCenter&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; width_tablet=&#8221;100%&#8221; width_phone=&#8221;100%&#8221; width_last_edited=&#8221;on|tablet&#8221; custom_padding=&#8221;30px||30px||true|false&#8221; custom_padding_tablet=&#8221;0px|20px||20px|false|false&#8221; custom_padding_phone=&#8221;|20px||20px|false|false&#8221; border_color_top=&#8221;#3E92AC&#8221; border_color_bottom=&#8221;#F47920&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_heading title=&#8221;ExPRESS<sup>\u2122<\/sup>: OUR PROPRIETARY eTIL<SUP>\u00ae<\/SUP> MANUFACTURING PROCESS&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; title_level=&#8221;h3&#8243; title_font=&#8221;|800|||||||&#8221; title_text_color=&#8221;#3E92AC&#8221; title_font_size=&#8221;24px&#8221; title_line_height=&#8221;28px&#8221; custom_margin=&#8221;||10px||false|false&#8221; title_font_size_tablet=&#8221;20px&#8221; title_font_size_phone=&#8221;20px&#8221; title_font_size_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_heading][et_pb_text _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; text_font_size=&#8221;20px&#8221; text_line_height=&#8221;27px&#8221; width=&#8221;90%&#8221; width_tablet=&#8221;100%&#8221; width_phone=&#8221;&#8221; width_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;0px|||||&#8221; custom_padding_tablet=&#8221;0px|||||&#8221; custom_padding_phone=&#8221;0px|||||&#8221; custom_padding_last_edited=&#8221;on|tablet&#8221; text_font_size_tablet=&#8221;18px&#8221; text_font_size_phone=&#8221;18px&#8221; text_font_size_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>The clinical manufacture of TIL has historically required a complex and lengthy process<span>. <\/span><span>Traditionally, <\/span>TIL<span> <\/span><span>have been <\/span>obtained <span>solely <\/span>from surgically resected tumor samples and <span>their manufacture has involved<\/span> a multi-step process <span>with <\/span>the use of feeder cells.<\/p>\n<p>We have developed ExPRESS<sup>\u2122<\/sup> (<u>Ex<\/u> Vivo, <u>P<\/u>otent, <u>E<\/u>conomical, <u>S<\/u>treamlined, <u>S<\/u>imple), a proprietary, next-generation process to manufacture single and multiplex CRISPR\/Cas9-edited eTIL<span> therapies<\/span>. In comparison to historical TIL manufacturing processes, <strong>ExPRESS generates a cryopreserved CRISPR\/Cas9 edited eTIL product with a maximized potential to kill cancer cells.<\/strong> Furthermore, ExPRESS robustly manufactures eTIL <span>therapies <\/span>across a broad range of solid tumor types from surgical resections <strong>as well as Core Biopsies,<\/strong> potentially broadening the accessibility of eTIL <span>therapeutics <\/span>to patients unable to undergo surgical resection.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; width_tablet=&#8221;100%&#8221; width_phone=&#8221;100%&#8221; width_last_edited=&#8221;on|tablet&#8221; custom_padding_tablet=&#8221;0px|20px|0px|20px|false|false&#8221; custom_padding_phone=&#8221;|20px||20px|false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-content\/uploads\/2024\/06\/ksq-process.png&#8221; alt=&#8221;About-placeholder2&#8243; title_text=&#8221;ksq-process&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; width=&#8221;94%&#8221; custom_margin=&#8221;25px|||||&#8221; custom_margin_tablet=&#8221;0px||||false|false&#8221; custom_margin_phone=&#8221;0px||||false|false&#8221; custom_margin_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; text_font_size=&#8221;20px&#8221; text_line_height=&#8221;27px&#8221; width=&#8221;90%&#8221; width_tablet=&#8221;100%&#8221; width_phone=&#8221;&#8221; width_last_edited=&#8221;on|tablet&#8221; text_font_size_tablet=&#8221;18px&#8221; text_font_size_phone=&#8221;18px&#8221; text_font_size_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>To date, we have successfully manufactured our investigational eTIL therapies using our ExPRESS process across 10+ solid tumor types using a 22-day manufacturing process. We believe our process as it exists <strong>today manufactures the best potential eTIL therapies<\/strong> to deliver <strong>Regnase-1<\/strong> and <strong>SOCS1<\/strong> target benefits to cancer patients. We are working with CTMC, our manufacturing partner, to deliver our eTIL therapeutic candidates to patients as quickly as possible.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; admin_label=&#8221;Beyond&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;RGBA(255,255,255,0)&#8221; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_stops=&#8221;rgba(78,178,192,0.87) 2%|rgba(78,178,192,0.87) 99%&#8221; background_color_gradient_overlays_image=&#8221;on&#8221; background_image=&#8221;https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-content\/uploads\/2024\/06\/iStock-538032878-BW-scaled-e1718320421472.jpg&#8221; parallax=&#8221;on&#8221; background_enable_video_mp4=&#8221;off&#8221; custom_padding=&#8221;60px||60px||false|false&#8221; custom_padding_tablet=&#8221;50px||30px||false|false&#8221; custom_padding_phone=&#8221;50px||30px||false|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; width_tablet=&#8221;100%&#8221; width_phone=&#8221;100%&#8221; width_last_edited=&#8221;on|tablet&#8221; custom_padding_tablet=&#8221;0px|20px|0px|20px|false|false&#8221; custom_padding_phone=&#8221;|20px||20px|false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_heading title=&#8221;BEYOND OUR eTIL PROGRAMS&#8221; admin_label=&#8221;Heading&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; title_level=&#8221;h3&#8243; title_font=&#8221;|800|||||||&#8221; title_text_color=&#8221;#FFFFFF&#8221; title_font_size=&#8221;24px&#8221; title_line_height=&#8221;34px&#8221; custom_margin=&#8221;||10px||false|false&#8221; custom_margin_tablet=&#8221;||0px||false|false&#8221; custom_margin_phone=&#8221;||0px||false|false&#8221; custom_margin_last_edited=&#8221;on|phone&#8221; title_font_size_tablet=&#8221;20px&#8221; title_font_size_phone=&#8221;20px&#8221; title_font_size_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_heading][et_pb_text _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#ffffff&#8221; text_font_size=&#8221;20px&#8221; text_line_height=&#8221;27px&#8221; text_font_size_tablet=&#8221;18px&#8221; text_font_size_phone=&#8221;18px&#8221; text_font_size_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>As we advance our in-house oncology programs, we continue to explore the full potential of our disruptive targets through the continued discovery of novel candidates. We also continue to explore new biology using our CRISPRomics platform in additional cell types in therapeutic areas outside of oncology in support of new in-house as well as partnered opportunities.<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;#&#8221; button_text=&#8221;CONTACT US&#8221; admin_label=&#8221;Button&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;14px&#8221; button_text_color=&#8221;#FFFFFF&#8221; button_border_width=&#8221;1px&#8221; button_border_color=&#8221;#FFFFFF&#8221; button_border_radius=&#8221;0px&#8221; button_letter_spacing=&#8221;1px&#8221; button_font=&#8221;|700||on|||||&#8221; button_use_icon=&#8221;off&#8221; custom_padding=&#8221;10px|25px|10px|25px|true|true&#8221; button_text_color_last_edited=&#8221;off|desktop&#8221; global_colors_info=&#8221;{}&#8221; button_text_color__hover_enabled=&#8221;on|hover&#8221; button_text_color__hover=&#8221;#FFFFFF&#8221; button_bg_color__hover_enabled=&#8221;on|desktop&#8221; button_bg_color__hover=&#8221;#2B6B89&#8243; button_bg_enable_color__hover=&#8221;on&#8221;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;|120px|||false|false&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Banner Section&#8221; module_class=&#8221;lightBlueShape innerBanner&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; background_enable_image=&#8221;off&#8221; background_video_mp4=&#8221;https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-content\/uploads\/2024\/06\/iStock-537852616-edit.mp4&#8243; height=&#8221;500px&#8221; overflow-x=&#8221;hidden&#8221; overflow-y=&#8221;hidden&#8221; custom_padding=&#8221;180px||180px||true|false&#8221; bottom_divider_height=&#8221;500px&#8221; hover_enabled=&#8221;0&#8243; da_popup_slug=&#8221;platform&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; title_text=&#8221;iStock-537852616-edit&#8221; sticky_enabled=&#8221;0&#8243; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; max_width=&#8221;100%&#8221; overflow-x=&#8221;hidden&#8221; overflow-y=&#8221;hidden&#8221; custom_margin=&#8221;|60px||60px|false|true&#8221; custom_margin_tablet=&#8221;|20px||20px|false|true&#8221; custom_margin_phone=&#8221;|20px||20px|false|true&#8221; custom_margin_last_edited=&#8221;on|tablet&#8221; custom_padding_tablet=&#8221;0px||0px||false|false&#8221; custom_padding_phone=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Vertical Line&#8221; _builder_version=&#8221;4.24.2&#8243; _module_preset=&#8221;default&#8221; positioning=&#8221;absolute&#8221; width=&#8221;100%&#8221; height=&#8221;100%&#8221; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"<!-- wp:divi\/placeholder \/-->","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"class_list":["post-732","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-json\/wp\/v2\/pages\/732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-json\/wp\/v2\/comments?post=732"}],"version-history":[{"count":96,"href":"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-json\/wp\/v2\/pages\/732\/revisions"}],"predecessor-version":[{"id":3172,"href":"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-json\/wp\/v2\/pages\/732\/revisions\/3172"}],"wp:attachment":[{"href":"https:\/\/s2.designcostaging.com\/clients\/ksqtherapeutics\/wp-json\/wp\/v2\/media?parent=732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}